+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Drug Formulation Market by Dosage Form (Inhalation Formulations, Oral Formulations, Parenteral Formulations), Technology (Immediate-Release Formulations, Liposomal Formulations, Microsphere Formulations), Therapeutic Area, End User - Forecast 2024-2030- Product Image
Global Drug Formulation Market by Dosage Form (Inhalation Formulations, Oral Formulations, Parenteral Formulations), Technology (Immediate-Release Formulations, Liposomal Formulations, Microsphere Formulations), Therapeutic Area, End User - Forecast 2024-2030- Product Image
Sale

Global Drug Formulation Market by Dosage Form (Inhalation Formulations, Oral Formulations, Parenteral Formulations), Technology (Immediate-Release Formulations, Liposomal Formulations, Microsphere Formulations), Therapeutic Area, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967541
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Formulation Market size was estimated at USD 2.42 trillion in 2023, USD 2.55 trillion in 2024, and is expected to grow at a CAGR of 5.70% to reach USD 3.56 trillion by 2030.

Drug formulation refers to the process through which active pharmaceutical ingredients (APIs) are combined with other substances to create a final medicinal product that is safe, effective, and convenient for patients to use. This technical and intricate process involves choosing suitable excipients to ensure the stability, bioavailability, and optimal performance of the API in the human body. The prevalence of chronic diseases, advancements in drug delivery technologies, and the escalation of personalized medicine have been elevating the need for more drug formulations.

Despite the immense potential, drug formulation faces challenges such as the high cost of development, regulatory hurdles, and the complexity of creating formulations that are both stable and acceptable to patients in terms of taste and administration method. Addressing these restraints requires continuous investment in R&D, adopting innovative technologies, and ensuring regulatory strategies are adaptable and efficient. The exploration of novel drug delivery systems such as nanotechnology, sustained-release formulations, and biodegradable polymers is expected to further enhance drug efficacy and patient compliance, potentially transforming the landscape of pharmaceutical care.

Regional Insights

In the Americas, especially the United States, there is a significant emphasis on innovative drug formulation technologies due to the presence of major pharmaceutical companies and a well-established regulatory framework led by the FDA. This promotes a high level of investment in research and development (R&D), focusing on complex formulations such as biologics and sustained-release drugs. The production capacity in the Americas is also bolstered by advanced manufacturing facilities, enabling rapid scalability of new formulations. APAC is rapidly emerging as a key player in the drug formulation market, driven by increasing healthcare expenditure, growing demand for generic medicines, and improvements in regulatory frameworks.

Countries like India and China are leading in the production of generics, leveraging cost-effective manufacturing and a large pool of scientific talent. The EMEA region presents a mature market with a strong focus on high-quality drug formulations and stringent regulatory standards, especially in the European Union (EU) countries. Companies in the EMEA region are leading in advanced drug delivery systems and personalized medicine, supported by robust healthcare systems and significant government and private investment in pharmaceutical R&D.

Market Trends by Segment

  • Dosage Form: Convenience and effectiveness of oral formulations for chronic treatments
  • End User: Rising investments in drug developments by pharmaceutical companies

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Glenmark Launches Triple Drug Formulation for Type 2 Diabetes Patients in India

Glenmark Pharmaceuticals introduced a pioneering triple-drug combination therapy for managing Type 2 Diabetes Mellitus in India. This innovative formulation, branded as 'Triarchy,' integrates three key active ingredients - Remogliflozin, Vildagliptin, and Metformin into a single tablet. Triarchy is engineered to address the challenges associated with managing blood sugar levels, offering a simplified regimen that could transform treatment adherence and patient outcomes.

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formulation

Neurocrine Biosciences has successfully received acceptance from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) of Ingrezza (valbenazine) oral granules in a sprinkle formulation. This pivotal advancement underscores Neurocrine Biosciences' dedication to enhancing patient-centered care through innovative drug formulations. The oral granule formulation is designed for ease of administration, catering to patients who may encounter difficulties with traditional pill forms.

Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques

Merck joined forces with XtalPi, a pioneer in pharmaceutical digitalization, to revolutionize drug formulations by integrating AI-powered artificial intelligence methodologies. This partnership aims to harness cutting-edge AI technology to streamline the development process, enhance drug performance, and expedite the delivery of innovative medical solutions to the market. By leveraging XtalPi's Intelligent Digital Drug Discovery and Development (ID4) platform, Merck intends to optimize the physicochemical properties of pharmaceuticals, ensuring higher efficacy, improved patient compliance, and faster time-to-market for critical medications.

Key Company Profiles

The report delves into recent significant developments in the Drug Formulation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AbbVie Inc., Amgen, Inc., AstraZeneca plc., Bayer AG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Catalent, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Gilead Sciences, Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Halozyme Therapeutics, Inc., Johnson & Johnson Services, Inc., Marksans Pharma Ltd., Medicef Pharma, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceuticals Industries Ltd., and The Bristol-Myers Squibb Company.

This research report offers invaluable insights into various crucial aspects of the Drug Formulation Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for effective treatments
5.1.1.2. Government initiatives encouraging drug development and discovery
5.1.1.3. Rise of personalized and tailored medicine and therapies
5.1.2. Restraints
5.1.2.1. Adverse recalls of drugs and medications
5.1.3. Opportunities
5.1.3.1. Advancements in drug delivery and dosage technologies
5.1.3.2. Investments in CDMOs to develop generic drugs
5.1.4. Challenges
5.1.4.1. Complex development and processing of drug formulations
5.2. Market Segmentation Analysis
5.2.1. Dosage Form: Convenience and effectiveness of oral formulations for chronic treatments
5.2.2. End User: Rising investments in drug developments by pharmaceutical companies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Drug Formulation Market, by Dosage Form
6.1. Introduction
6.2. Inhalation Formulations
6.3. Oral Formulations
6.4. Parenteral Formulations
6.5. Topical Formulations
7. Drug Formulation Market, by Technology
7.1. Introduction
7.2. Immediate-Release Formulations
7.3. Liposomal Formulations
7.4. Microsphere Formulations
7.5. Modified-Release Formulations
7.6. Nanoformulations
7.7. Self-Emulsifying Drug Delivery Systems
7.8. Solid Dispersion Formulations
8. Drug Formulation Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.3. Central Nervous System
8.4. Dermatology
8.5. Endocrinology
8.6. Gastrointestinal
8.7. Immunology
8.8. Infectious Diseases
8.9. Oncology
8.10. Ophthalmology
8.11. Pain Management
8.12. Respiratory
9. Drug Formulation Market, by End User
9.1. Introduction
9.2. Academic & Research Institutions
9.3. Contract Development & Manufacturing Organizations
9.4. Hospitals & Clinics
9.5. Pharmaceutical Companies
10. Americas Drug Formulation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Formulation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Formulation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Glenmark Launches Triple Drug Formulation for Type 2 Diabetes Patients in India
13.3.2. Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formulation
13.3.3. Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. DRUG FORMULATION MARKET RESEARCH PROCESS
FIGURE 2. DRUG FORMULATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG FORMULATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG FORMULATION MARKET DYNAMICS
FIGURE 7. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DRUG FORMULATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. DRUG FORMULATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG FORMULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG FORMULATION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DRUG FORMULATION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG FORMULATION MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DRUG FORMULATION MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG FORMULATION MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DRUG FORMULATION MARKET SIZE, BY NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG FORMULATION MARKET SIZE, BY PRESSURIZED METERED DOSE INHALER, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DRUG FORMULATION MARKET SIZE, BY PRESSURIZED METERED DOSE INHALER, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG FORMULATION MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DRUG FORMULATION MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG FORMULATION MARKET SIZE, BY GUMMIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DRUG FORMULATION MARKET SIZE, BY GUMMIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG FORMULATION MARKET SIZE, BY LOZENGES & PASTILLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DRUG FORMULATION MARKET SIZE, BY LOZENGES & PASTILLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS & GRANULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS & GRANULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG FORMULATION MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DRUG FORMULATION MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG FORMULATION MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DRUG FORMULATION MARKET SIZE, BY EMULSIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG FORMULATION MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DRUG FORMULATION MARKET SIZE, BY SUSPENSIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG FORMULATION MARKET SIZE, BY CREAMS, LOTIONS, & FOAMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL DRUG FORMULATION MARKET SIZE, BY CREAMS, LOTIONS, & FOAMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, TINCTURES, & POWDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, TINCTURES, & POWDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG FORMULATION MARKET SIZE, BY OINTMENTS & OILS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL DRUG FORMULATION MARKET SIZE, BY OINTMENTS & OILS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG FORMULATION MARKET SIZE, BY PASTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL DRUG FORMULATION MARKET SIZE, BY PASTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG FORMULATION MARKET SIZE, BY SPRAYS & PATCHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL DRUG FORMULATION MARKET SIZE, BY SPRAYS & PATCHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMEDIATE-RELEASE FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMEDIATE-RELEASE FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG FORMULATION MARKET SIZE, BY LIPOSOMAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL DRUG FORMULATION MARKET SIZE, BY LIPOSOMAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG FORMULATION MARKET SIZE, BY MICROSPHERE FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL DRUG FORMULATION MARKET SIZE, BY MICROSPHERE FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG FORMULATION MARKET SIZE, BY MODIFIED-RELEASE FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL DRUG FORMULATION MARKET SIZE, BY MODIFIED-RELEASE FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG FORMULATION MARKET SIZE, BY NANOFORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL DRUG FORMULATION MARKET SIZE, BY NANOFORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG FORMULATION MARKET SIZE, BY SELF-EMULSIFYING DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL DRUG FORMULATION MARKET SIZE, BY SELF-EMULSIFYING DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLID DISPERSION FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLID DISPERSION FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG FORMULATION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL DRUG FORMULATION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG FORMULATION MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL DRUG FORMULATION MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG FORMULATION MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL DRUG FORMULATION MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG FORMULATION MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL DRUG FORMULATION MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG FORMULATION MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL DRUG FORMULATION MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG FORMULATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL DRUG FORMULATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG FORMULATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL DRUG FORMULATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG FORMULATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL DRUG FORMULATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG FORMULATION MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL DRUG FORMULATION MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG FORMULATION MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL DRUG FORMULATION MARKET SIZE, BY RESPIRATORY, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG FORMULATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL DRUG FORMULATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG FORMULATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 106. GLOBAL DRUG FORMULATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG FORMULATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 108. GLOBAL DRUG FORMULATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG FORMULATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 110. GLOBAL DRUG FORMULATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 111. AMERICAS DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 112. AMERICAS DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 113. AMERICAS DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 114. AMERICAS DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 115. AMERICAS DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 116. AMERICAS DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 117. AMERICAS DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 118. AMERICAS DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 119. AMERICAS DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 120. AMERICAS DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 121. AMERICAS DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. AMERICAS DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. AMERICAS DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 124. AMERICAS DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 125. AMERICAS DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 126. AMERICAS DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 127. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 128. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 129. ARGENTINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 130. ARGENTINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 131. ARGENTINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 132. ARGENTINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 133. ARGENTINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 134. ARGENTINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 135. ARGENTINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 136. ARGENTINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 137. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 138. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 139. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. ARGENTINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 142. ARGENTINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 143. ARGENTINA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 144. ARGENTINA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 145. BRAZIL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 146. BRAZIL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 147. BRAZIL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 148. BRAZIL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 149. BRAZIL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 150. BRAZIL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 151. BRAZIL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 152. BRAZIL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 153. BRAZIL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 154. BRAZIL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 155. BRAZIL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. BRAZIL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. BRAZIL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 158. BRAZIL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 159. BRAZIL DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 160. BRAZIL DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 161. CANADA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 162. CANADA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 163. CANADA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 164. CANADA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 165. CANADA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 166. CANADA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 167. CANADA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 168. CANADA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 169. CANADA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 170. CANADA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 171. CANADA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 172. CANADA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 173. CANADA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 174. CANADA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 175. CANADA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. CANADA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. MEXICO DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 178. MEXICO DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 179. MEXICO DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 180. MEXICO DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 181. MEXICO DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 182. MEXICO DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 183. MEXICO DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 184. MEXICO DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 185. MEXICO DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 186. MEXICO DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 187. MEXICO DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. MEXICO DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. MEXICO DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 190. MEXICO DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 191. MEXICO DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. MEXICO DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. UNITED STATES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 194. UNITED STATES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 195. UNITED STATES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 196. UNITED STATES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 197. UNITED STATES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 198. UNITED STATES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 199. UNITED STATES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 200. UNITED STATES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 201. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 202. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 203. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. UNITED STATES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 206. UNITED STATES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 207. UNITED STATES DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 208. UNITED STATES DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 209. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 210. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 212. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 214. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 216. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 218. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 220. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 224. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 226. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 228. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 229. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 230. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 231. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 232. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 233. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 234. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 235. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 236. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 237. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 238. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 239. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 242. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 243. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. CHINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 246. CHINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 247. CHINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 248. CHINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 249. CHINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 250. CHINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 251. CHINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 252. CHINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 253. CHINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 254. CHINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 255. CHINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 256. CHINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 257. CHINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 258. CHINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 259. CHINA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. CHINA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. INDIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 262. INDIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 263. INDIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 264. INDIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 265. INDIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 266. INDIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 267. INDIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 268. INDIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 269. INDIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 270. INDIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 271. INDIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. INDIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. INDIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 274. INDIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 275. INDIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. INDIA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. INDONESIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 278. INDONESIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 279. INDONESIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 280. INDONESIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 281. INDONESIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 282. INDONESIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 283. INDONESIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 284. INDONESIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 285. INDONESIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 286. INDONESIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 287. INDONESIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 288. INDONESIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 289. INDONESIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 290. INDONESIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 291. INDONESIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 292. INDONESIA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 293. JAPAN DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 294. JAPAN DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 295. JAPAN DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 296. JAPAN DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 297. JAPAN DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 298. JAPAN DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 299. JAPAN DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 300. JAPAN DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 301. JAPAN DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 302. JAPAN DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 303. JAPAN DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 304. JAPAN DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 305. JAPAN DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 306. JAPAN DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 307. JAPAN DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 308. JAPAN DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 309. MALAYSIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 310. MALAYSIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 311. MALAYSIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 312. MALAYSIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 313. MALAYSIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 314. MALAYSIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 315. MALAYSIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 316. MALAYSIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 317. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 318. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 319. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. MALAYSIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 322. MALAYSIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 323. MALAYSIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. MALAYSIA DRUG FORMULATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 326. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 327. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 328. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 329. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 330. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 331. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 332. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 333. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 334. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 335. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 336. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 337. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 338. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILL

Companies Mentioned

  • 3M Company
  • AbbVie Inc.
  • Amgen, Inc.
  • AstraZeneca plc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Catalent, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Halozyme Therapeutics, Inc.
  • Johnson & Johnson Services, Inc.
  • Marksans Pharma Ltd.
  • Medicef Pharma
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Industries Ltd.
  • The Bristol-Myers Squibb Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.55 Trillion
Forecasted Market Value ( USD ) by 2030 $ 3.56 Trillion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Drug Formulation Global Market Report 2024 - Product Image

Drug Formulation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Spirulina Market by Type (Arthrospira Maxima, Arthrospira Platensis), Drug Formulation (Granule & Gelling Agent, Liquid, Powder), Application - Forecast 2024-2030 - Product Image

Global Spirulina Market by Type (Arthrospira Maxima, Arthrospira Platensis), Drug Formulation (Granule & Gelling Agent, Liquid, Powder), Application - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Doxorubicin Market by Drug Formulation (Doxorubicin Injection, Lyophilized Powder), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application - Forecast 2024-2030 - Product Image

Global Doxorubicin Market by Drug Formulation (Doxorubicin Injection, Lyophilized Powder), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Oral Solid Dosage Pharmaceutical Formulation Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Oral Solid Dosage Pharmaceutical Formulation Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From
A Journal of Drug Formulation, Development and Production - Product Image

A Journal of Drug Formulation, Development and Production

  • Journal Icon Journal
  • 60 Pages
  • Global
From

About the Drug Formulation Market

The Drug Formulation market is a key component of the Drug Discovery process. It involves the development of a drug product that is suitable for administration to a patient. This includes the selection of the appropriate drug delivery system, the optimization of the drug's physical and chemical properties, and the development of a manufacturing process. The formulation of a drug is a complex process that requires expertise in a variety of disciplines, including chemistry, pharmacology, and engineering. The Drug Formulation market is highly competitive, with a number of companies offering a range of services. These include formulation development, analytical testing, and manufacturing. Companies in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.